BECOTATUG VEDOTIN

Clinical trials for BECOTATUG VEDOTIN explained in plain language.

Never miss a new study

Get alerted when new BECOTATUG VEDOTIN trials appear

Sign up with your email to follow new studies for BECOTATUG VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Triple therapy hope for tough esophageal cancer

Disease control Not yet recruiting

This study tests a new three-drug combination for people with advanced esophageal squamous cell carcinoma (ESCC) who have not had prior treatment. The drugs include an antibody-drug conjugate (becotatug vedotin) that targets cancer cells, an immunotherapy (tislelizumab), and stan…

Matched conditions: BECOTATUG VEDOTIN

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated May 01, 2026 20:41 UTC

BECOTATUG VEDOTIN

Get alerted when new BECOTATUG VEDOTIN trials appear

Triple therapy hope for tough esophageal cancer